Home › NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone
 

Keywords :   


NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone

2015-11-18 20:49:12| Agriculture - Topix.net

Australian biopharmaceutical Company Immuron Limited is pleased to announce that the Company's Phase IIb, the IMM-124E clinical trial for the treatment of NASH , has successfully passed its 25% recruitment milestone with 35 patients having been successfully randomized into either arms. Immuron continues to drive its NASH clinical trial recruitment to meet its enrollment goal of 120 biopsy-proven NASH subjects by June 2016.

Tags: patient clinical trail recruitment

Category:Agriculture and Forestry

Latest from this category

All news
05.11Delayed implementation of EID eartag rule requested
05.11Why forage is the cornerstone of a working ranch horses diet
05.11American Angus elects 2024-25 board leaders
05.11Brazil gives green light to medicinal use of Cannabis in animals
05.11Farmer sentiment in October rebounds ahead of the U.S. election
05.11We might not like it, but overhead must be evaluated
05.11Phibro Animal Health completes acquisition of Zoetis medicated feed additive portfolio
05.11November/December 2024 Digital Edition of National Hog Farmer now available
Agriculture and Forestry »
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
05.11Why forage is the cornerstone of a working ranch horses diet
More »